NeoGenomics Reports 18% Revenue Growth and Strong Gains in Adjusted EBITDA
Go back to NeoGenomics Reports 18% Revenue Growth and Strong Gains in Adjusted EBITDA| NEOGENOMICS (NASDAQ: NEO) | Delayed: 17.59 +0.21 (1.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.38 | 52 Week High | $9.54 | |||
| Open | $17.15 | 52 Week Low | $5.49 | |||
| Day High | $17.84 | P/E | 439.75 | |||
| Day Low | $16.95 | EPS | $0.04 | |||
| Volume | 644,127 | |||||

